pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,899 catalysts · 3,189 8k filing · 1,751 grant · 1,000 device adverse event · 820 approval · 632 device 510k · 584 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 82 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-02-04×clear all
type
  • 8k filing3,189
  • grant1,751
  • device adverse event1,000
  • approval820
  • device 510k632
  • earnings584
  • device pma481
  • device recall194
  • phase 2 completion172
  • recall167
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Feb 9, 2026

    50
    ›Feb 13, 2026device recall181d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    MiniMed 740G Insulin Pump (MMT-1811, MMT-1812, MMT-1861, MMT-1862) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall181d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    Paradigm REAL-Time Revel Insulin Pump (MMT-523, MMT-723) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall181d agoMedline Industries, LP device recall (Cls II)

    Medline Kits containing ENFIT G-TUBE CONNECTOR 1. SKU DYKM2720 G/J TUBE CARE KIT 2. SKU ENFITDISCKIT ENFIT DISCHARGE KIT — Reason: Connectors were not manufactured to required dimensional specifications and may not form a proper seal with ENFit-style devices, which could lead to leakage. Leakage may result in delayed care and fluid loss. Additional consequences may also occur if user over-tightens the connector to stop the leakage, including additional clinical intervention, risk of infection, patient discomfort, and prolonged recovery process. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall181d agoMerit Medical Systems, Inc. device recall (Cls I)MERIT MEDICAL SYSTEMS INC

    16F Dual Valved Splittable Sheath Introducer (bulk, non-sterile), REF: FCL-174-00/B — Reason: 16F dual-valved splittable sheath introducer due to a design defect, may not split as intended, which may result in hemorrhage, foreign bodies, procedure delay, embolization/thrombosis, impaired catheter function, loss of vessel for future vascular access. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall181d agoMedline Industries, LP device recall (Cls II)

    ENFIT G-TUBE CONNECTOR, MEDLINE Item No. ENFIT1010GC — Reason: Connectors were not manufactured to required dimensional specifications and may not form a proper seal with ENFit-style devices, which could lead to leakage. Leakage may result in delayed care and fluid loss. Additional consequences may also occur if user over-tightens the connector to stop the leakage, including additional clinical intervention, risk of infection, patient discomfort, and prolonged recovery process. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall181d agoMerit Medical Systems, Inc. device recall (Cls I)MERIT MEDICAL SYSTEMS INC

    BioFlo DuraMax Catheter, REF: H965103028011/A, H965103028021/A, H965103028021/EU, H965103028031/A, H965103028031/EU, H965103028041/A, H965103028041/EU, H965103028051/A, H965103028051/EU, H965103028061/A, H965103028061/EU, H965103028070/A, H965103028070/EU, H965103028080/A, H965103028080/EU, H965103028090/A, H965103028090/EU, H965103028161/A, H965103028181/A, H965103028191/A, H965103028191/EU, H965103028201/A, H965103028211/A, H965103028220/A, H965103028230/A, H965103028240/A, H965103038181/A — Reason: 16F dual-valved splittable sheath introducer due to a design defect, may not split as intended, which may result in hemorrhage, foreign bodies, procedure delay, embolization/thrombosis, impaired catheter function, loss of vessel for future vascular access. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall181d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    MiniMed 530G Insulin Pump (MMT-551, MMT-751) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall181d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    MiniMed 780G Insulin Pump (MMT-1884, MMT-1885, MMT-1886, MMT-1894, MMT-1895, MMT-1896) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall181d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    MiniMed 640G Insulin Pump (MMT-1711, MMT-1712, MMT-1751, MMT-1752) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall181d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    MiniMed 630G Insulin Pump (MMT-1714, MMT-1715, MMT-1754, MMT-1755) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall181d agoMerit Medical Systems, Inc. device recall (Cls I)MERIT MEDICAL SYSTEMS INC

    DuraMax Chronic Hemodialysis Catheter, REF: H787103028015/A, H787103028025/A, H787103028031/A, H787103028035/A, H787103028041/A, H787103028045/A, H787103028051/A, H787103028055/A, H787103028061/A, H787103028075/A, H787103028085/A, H787103028095/A, H787103028165/A, H787103028181/A, H787103028185/A, H787103028191/A, H787103028195/A, H787103028205/A, H787103028215/A, H787103028225/A, H787103028235/A — Reason: 16F dual-valved splittable sheath introducer due to a design defect, may not split as intended, which may result in hemorrhage, foreign bodies, procedure delay, embolization/thrombosis, impaired catheter function, loss of vessel for future vascular access. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall181d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    MiniMed 770G Insulin Pump (MMT-1880, MMT-1881, MMT-1882, MMT-1890, MMT-1891, MMT-1892) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall181d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    MiniMed 700G Insulin Pump (MMT-1801, MMT-1805, MMT-1850, MMT-1851) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026device recall181d agoMedtronic MiniMed, Inc. device recall (Cls II)Medtronic USA Inc

    MiniMed 670G Insulin Pump (MMT-1760, MMT-1761, MMT-1762, MMT-1780, MMT-1781, MMT-1782) — Reason: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 13, 2026grant181d agoUNIVERSITY OF WASHINGTON — Spatial Patterining in Zebrafish Inner EarUniversity of Washington

    DC grant. $490,487. PI: David W Raible

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoUNIVERSITY OF CALIFORNIA AT DAVIS — Restoring Gastrointestinal Microbiota-Host Interactions to Prevent Invasive C...

    AI grant. $441,204. PI: Derek J Bays

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — The role of tissue-resident T cells in osteoarthritis during the transition t...

    AI grant. $452,375. PI: Adam Mor

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoST. JUDE CHILDREN'S RESEARCH HOSPITAL — A method for engineering high-fidelity regulatory T cells

    AI grant. $508,750. PI: Yongqiang Feng

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoUNIVERSITY OF TEXAS MED BR GALVESTON — Novel Artificial Intelligence approaches to distinguish allergenic from non-a...

    AI grant. $429,499. PI: WERNER A BRAUN

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoUNIVERSITY OF CALIFORNIA AT DAVIS — Antigen identification for Chlamydia vaccine development

    AI grant. $404,570. PI: STEPHEN J MCSORLEY

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoUNIVERSITY OF CALIFORNIA AT DAVIS — The role of Entamoeba histolytica trogocytosis (trogo-: nibble) in the pathog...

    AI grant. $744,328. PI: Katherine S Ralston

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoWAYNE STATE UNIVERSITY — Translating Phage-Antibiotic Synergy to Combat Multi-Drug Resistant Staphyloc...

    AI grant. $670,529. PI: Michael Joseph Rybak

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoUNIVERSITY OF FLORIDA — Potassium channel regulation of the antiviral immune system and viral replica...University of Florida

    AI grant. $681,110. PI: Daniel Swale

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoDARTMOUTH COLLEGE — Impact of a Dual Function Type VI Secretion System (T6SS) Immunity Protein on...

    AI grant. $825,054. PI: Jennifer Melinda Bomberger

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoSTANFORD UNIVERSITY — Cryo-EM structures of herpesvirus glycoprotein complexes in native membranes:...Stanford University

    AI grant. $246,881. PI: Stefan Lyne Oliver

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoBAYLOR COLLEGE OF MEDICINE — COMPOSITION-DEPENDENT CONTROL OF NUCLEOLI AND NUCLEOLAR-DERIVED CONDENSATESBaylor College of Medicine

    GM grant. $440,000. PI: Joshua A Riback

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Mechanism of local and systemic allergies against protease allergens

    AI grant. $416,279. PI: YOSUKE KUMAMOTO

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoST. JUDE CHILDREN'S RESEARCH HOSPITAL — Define regulatory T cell repertoire sustainability

    AI grant. $880,417. PI: Yongqiang Feng

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoTEXAS A&M UNIVERSITY — Dietary regulation of sleep in a blood-feeding insect

    AI grant. $411,704. PI: Zach N. Adelman

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoUNIVERSITY OF MINNESOTA — Targeting Host Factors Essential for EBV Episome PersistenceUniversity of Minnesota

    AI grant. $224,368. PI: Chong Wang

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoHENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES — Genetic control of early Mycobacterium tuberculosis inflammatory responses

    AI grant. $447,960. PI: Andrew Olive

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Effects of Sleep Loss on Memory Consolidation Within a Corticothalamic CircuitUniversity of California San Francisco

    NS grant. $216,025. PI: Jessica C Jimenez

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoSCRIPPS RESEARCH INSTITUTE, THE — Advancing HIV Vaccine Development with a Lipid Nanodisc PlatformDelSiTech Ltd

    AI grant. $511,531. PI: Kimmo Ilmari Rantalainen

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoWEST VIRGINIA UNIVERSITY — Symbiosis-driven nutrient transporters: Central to tsetse fly biology

    AI grant. $418,985. PI: Rita V M Rio

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoIOWA STATE UNIVERSITY — Overcoming innate drug efflux systems to expand anthelmintic vulnerability

    AI grant. $453,063. PI: Matthew Brewer

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoSAINT LOUIS UNIVERSITY — Molecular mechanisms of MCP-1 polymorphism-mediated susceptibility to pulmona...

    AI grant. $192,500. PI: Jianguo Liu

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoUNIVERSITY OF TEXAS HLTH SCIENCE CENTER — Lymphotoxin-dependent control of long COVID

    AI grant. $234,715. PI: Alexei V Tumanov

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoUNIVERSITY OF CONNECTICUT SCH OF MED/DNT — Mechanisms of translation response to stress

    GM grant. $457,875. PI: OSCAR VARGAS-RODRIGUEZ

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - FIELD CENTER (FC) - TASK AREA A

    HL grant. $437,119. PI: HENRY N GINSBERG

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoUNIVERSITY OF KANSAS MEDICAL CENTER — Hepatic Lymphatics and the Immune Response in Acute Liver FailureUniversity of Kansas Medical Center

    AI grant. $426,250. PI: Anup Ramachandran

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoSTOWERS INSTITUTE FOR MEDICAL RESEARCH — Function of maternal mRNA during zebrafishembryogenesis

    GM grant. $429,000. PI: Ariel Bazzini

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoUNIVERSITY OF CENTRAL FLORIDA — Nasal microbiome-derived antimicrobial factors to inhibit Staphylococcus aure...

    AI grant. $422,125. PI: ALEXANDER MICHAEL COLE

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoUNIVERSITY OF COLORADO DENVER — Inhibition of Staphylococcus aureus virulence by Corynebacterium secreted fac...University of Colorado Denver

    AI grant. $186,953. PI: Sarah E Clark

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoDUKE UNIVERSITY — Prognostic Biomarkers in Invasive CandidiasisDuke University

    AI grant. $242,250. PI: Micah T. McClain

    full page →nih reporter ↗
    ›Feb 13, 2026grant181d agoMEDICAL COLLEGE OF WISCONSIN — Defining the Role of Angiotensin II Type 2 Receptor in Bladder Physiology and...Platform Therapeutics Inc

    DK grant. $50,114. PI: Hannah A Anderson

    full page →nih reporter ↗
    ›Feb 15, 2026approval179d agoAMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approvalamoxicillin

    Sponsor: AUROBINDO PHARMA LTD. Form: FOR SUSPENSION. Route: ORAL

    full page →amoxicillin →fda approvals ↗
    ›Feb 15, 2026grant179d agoUNIVERSITY OF CALIFORNIA-IRVINE — Patch for hemodynamic and hemorrhage monitoring

    AG grant. $408,504. PI: BERNARD CHOI

    full page →nih reporter ↗
    ›Feb 15, 2026grant179d agoUT SOUTHWESTERN MEDICAL CENTER — CMT4A and CMT2K Gene Replacement Therapy with AAV9/GDAP1 in Rats

    NS grant. $249,000. PI: Xin Chen

    full page →nih reporter ↗
    ›Feb 15, 2026grant179d agoMASSACHUSETTS GENERAL HOSPITAL — Clinical Spectrum and Societal Impact of Cognitive Impairment, Alzheimer's an...Massachusetts General Hospital

    AG grant. $738,105. PI: MARK J SIEDNER

    full page →nih reporter ↗
    ›Feb 15, 2026grant179d agoINDIANA UNIVERSITY INDIANAPOLIS — MR1/MAIT cell axis-mediated regulation of inflammatory responses

    AG grant. $624,837. PI: Randy R Brutkiewicz

    full page →nih reporter ↗
    ← prev
    page 12 of 178
    next →
    $MMSI91.20+0.10%
    $MMSI91.20+0.10%
    $MMSI91.20+0.10%